EMA: Draft GL for OIPs [BE/BA News]

posted by Chirag – India, 2024-04-22 06:37 (56 d 00:33 ago) – Posting: # 23960
Views: 1,206

(edited by on 2024-04-22 06:48)

Dear Helmut,

Thank you for sharing.

Upon reading, I noticed that the recently introduced guidelines still relate to Directive 2001/20/EC rather than 536/2014. To the best of my knowledge, the revised guideline is effective from January 31, 2023. Trials that were authorized under the Clinical Trials Directive may be extended until January 31, 2025. If they are not finished by then, they will likewise be governed by the Clinical Trials Regulation and need to be registered in CTIS. I would like everyone to help me with this.

Since this is my first post, I apologize for any errors.

Regards,
Chirag

Complete thread:

UA Flag
Activity
 Admin contact
23,057 posts in 4,840 threads, 1,641 registered users;
142 visitors (0 registered, 142 guests [including 69 identified bots]).
Forum time: 07:10 CEST (Europe/Vienna)

If you tell the truth you don’t have to remember anything.    Mark Twain

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5